Thank you Brad Loncar for featuring our CEO, Nello Mainolfi, on BiotechTV to discuss Kymera's exciting achievements over the past year and how we’re harnessing the power of #TPD to develop differentiated medicines with the potential to address critical health problems and improve patients’ lives. #ReinventingMedicine
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Nello Mainolfi shares an update on Kymera Therapeutics and the progress of the protein degradation field. He gives updates on programs such as IRAK4, STAT6, TYK2, and STAT3, and describes learnings in protein degradation that Kymera has discovered since the last time BiotechTV visited the company one year ago. Full video: https://lnkd.in/gMPtZe2S BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent